Tango Therapeutics Appoints Robert Azelby to Board
Tango Therapeutics appointed Robert Azelby to its Board of Directors. His oncology commercialization expertise is viewed as a strategic asset as the company advances its pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day